NewsRx

Search our medical news database

HIV/AIDS Therapy

Trichosanthin ribosome suppression not linked to antiretroviral effects

Published in AIDS Weekly, April 28th, 2003

The antiretroviral effects of trichosanthin (TCS) are not linked to its effects on ribosomes.

TCS "is a type I ribosome-inactivating (RI) protein possessing multiple biological and pharmacological activities," researchers in China explained. "Its major action is inhibition of human immunodeficiency virus (HIV) replication but the mechanism is still elusive."

"Previous studies found that TCS mutants with reduced RI activity simultaneously lost some anti-HIV activity," noted J.H. Wang and coauthors at the Chinese Academy of Sciences.

However, "an exception was demonstrated by two TCS mutants retaining almost all RI activity but were...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook